Cargando…
Surgical Management of Hepatoblastoma and Recent Advances
Hepatoblastoma is the most common childhood liver malignancy. The management of hepatoblastoma requires multidisciplinary efforts. The five-year overall survival is approximately 80% in developed countries. Surgery remains the mainstay of treatment for hepatoblastoma, and meticulous techniques must...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966548/ https://www.ncbi.nlm.nih.gov/pubmed/31817219 http://dx.doi.org/10.3390/cancers11121944 |
_version_ | 1783488761118588928 |
---|---|
author | Yang, Tianyou Whitlock, Richard S. Vasudevan, Sanjeev A. |
author_facet | Yang, Tianyou Whitlock, Richard S. Vasudevan, Sanjeev A. |
author_sort | Yang, Tianyou |
collection | PubMed |
description | Hepatoblastoma is the most common childhood liver malignancy. The management of hepatoblastoma requires multidisciplinary efforts. The five-year overall survival is approximately 80% in developed countries. Surgery remains the mainstay of treatment for hepatoblastoma, and meticulous techniques must be employed to ensure safe and effective local control surgeries. Additionally, there have been several advances from both pediatric and adult literature in the way liver tumor surgery is performed. In this review, we highlight important aspects of liver surgery for hepatoblastoma, the management of metastatic disease, and the most current technical advances in performing these procedures in a safe and effective manner. |
format | Online Article Text |
id | pubmed-6966548 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69665482020-01-27 Surgical Management of Hepatoblastoma and Recent Advances Yang, Tianyou Whitlock, Richard S. Vasudevan, Sanjeev A. Cancers (Basel) Review Hepatoblastoma is the most common childhood liver malignancy. The management of hepatoblastoma requires multidisciplinary efforts. The five-year overall survival is approximately 80% in developed countries. Surgery remains the mainstay of treatment for hepatoblastoma, and meticulous techniques must be employed to ensure safe and effective local control surgeries. Additionally, there have been several advances from both pediatric and adult literature in the way liver tumor surgery is performed. In this review, we highlight important aspects of liver surgery for hepatoblastoma, the management of metastatic disease, and the most current technical advances in performing these procedures in a safe and effective manner. MDPI 2019-12-04 /pmc/articles/PMC6966548/ /pubmed/31817219 http://dx.doi.org/10.3390/cancers11121944 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Yang, Tianyou Whitlock, Richard S. Vasudevan, Sanjeev A. Surgical Management of Hepatoblastoma and Recent Advances |
title | Surgical Management of Hepatoblastoma and Recent Advances |
title_full | Surgical Management of Hepatoblastoma and Recent Advances |
title_fullStr | Surgical Management of Hepatoblastoma and Recent Advances |
title_full_unstemmed | Surgical Management of Hepatoblastoma and Recent Advances |
title_short | Surgical Management of Hepatoblastoma and Recent Advances |
title_sort | surgical management of hepatoblastoma and recent advances |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966548/ https://www.ncbi.nlm.nih.gov/pubmed/31817219 http://dx.doi.org/10.3390/cancers11121944 |
work_keys_str_mv | AT yangtianyou surgicalmanagementofhepatoblastomaandrecentadvances AT whitlockrichards surgicalmanagementofhepatoblastomaandrecentadvances AT vasudevansanjeeva surgicalmanagementofhepatoblastomaandrecentadvances |